Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment von Andrasik, Michele P., Broder, Gail B., Wallace, Stephaun E., Chaturvedi, Richa, Michael, Nelson L., Bock, Sally, Beyrer, Chris, Oseso, Linda, Aina, Jasmin, Lucas, Jonathan, Wilson, David R., Kublin, James G., Mensah, George A.

Volltext

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials von Broder, Gail B., Lucas, Jonathan P., Davis, Jontraye, Wallace, Stephaun E., Luthuli, Nandisile, Baepanye, Kagisho, White, Rhonda R., Bolton, Marcus, Blanchette, Cheryl, Andrasik, Michele P.

Volltext

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody von Edupuganti, Srilatha, Mgodi, Nyaradzo, Karuna, Shelly T., Andrew, Philip, Rudnicki, Erika, Kochar, Nidhi, deCamp, Allan, De La Grecca, Robert, Anderson, Maija, Karg, Carissa, Tindale, India, Greene, Elizabeth, Broder, Gail B., Lucas, Jonathan, Hural, John, Gallardo-Cartagena, Jorge A., Gonzales, Pedro, Frank, Ian, Sobieszczyk, Magdalena, Gomez Lorenzo, Margarita M., Burns, David, Anderson, Peter L., Miner, Maurine D., Ledgerwood, Julie, Mascola, John R., Gilbert, Peter B., Cohen, Myron S., Corey, Lawrence

Volltext

Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research von Siskind, Rona L, Andrasik, Michele, Karuna, Shelly T, Broder, Gail B, Collins, Clare, Liu, Albert, Lucas, Jonathan Paul, Harper, Gary W, Renzullo, Philip O

Volltext

Stigma, Implicit Bias, and Long-Lasting Prevention Interventions to End the Domestic HIV/AIDS Epidemic von Andrasik, Michele, Broder, Gail, Oseso, Linda, Wallace, Stephaun, Rentas, Francisco, Corey, Lawrence

Volltext

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine von Hammer, Scott M, Sobieszczyk, Magdalena E, Janes, Holly, Karuna, Shelly T, Mulligan, Mark J, Grove, Doug, Koblin, Beryl A, Buchbinder, Susan P, Keefer, Michael C, Tomaras, Georgia D, Frahm, Nicole, Hural, John, Anude, Chuka, Graham, Barney S, Enama, Mary E, Adams, Elizabeth, DeJesus, Edwin, Novak, Richard M, Frank, Ian, Bentley, Carter, Ramirez, Shelly, Fu, Rong, Koup, Richard A, Mascola, John R, Nabel, Gary J, Montefiori, David C, Kublin, James, McElrath, M. Juliana, Corey, Lawrence, Gilbert, Peter B

Volltext

A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru von Andrasik, Michele, Grove, Doug, Broder, Gail, Scott, Hyman, Allen, Mary, Karuna, Shelly

Volltext

A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016 von Huamani, Katherine Foy, Metch, Barbara, Broder, Gail, Andrasik, Michele

Volltext

Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical Trials von Andrasik, Michele Peake, Yoon, Ro, Mooney, Jessica, Broder, Gail, Bolton, Marcus, Votto, Teress, Davis-Vogel, Annet

Volltext

Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles von Goepfert, Paul A., Elizaga, Marnie L., Seaton, Kelly, Tomaras, Georgia D., Montefiori, David C., Sato, Alicia, Hural, John, DeRosa, Stephen C., Kalams, Spyros A., McElrath, M. Juliana, Keefer, Michael C., Baden, Lindsey R., Lama, Javier R., Sanchez, Jorge, Mulligan, Mark J., Buchbinder, Susan P., Hammer, Scott M., Koblin, Beryl A., Pensiero, Michael, Butler, Chris, Moss, Bernard, Robinson, Harriet L.

Volltext

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody von Edupuganti, Srilatha, Mgodi, Nyaradzo, Karuna, Shelly T., Andrew, Philip, Rudnicki, Erika, Kochar, Nidhi, deCamp, Allan, De La Grecca, Robert, Anderson, Maija, Karg, Carissa, Tindale, India, Greene, Elizabeth, Broder, Gail B., Lucas, Jonathan, Hural, John, Gallardo-Cartagena, Jorge A., Gonzales, Pedro, Frank, Ian, Sobieszczyk, Magdalena, Gomez Lorenzo, Margarita M, Burns, David, Anderson, Peter L., Miner, Maurine D., Ledgerwood, Julie, Mascola, John R., Gilbert, Peter B., Cohen, Myron S., Corey, Lawrence

Volltext

Inclusion of Transgender and Gender Non-conforming Communities in Preventive HIV Vaccine Research at the HIV Vaccine Trials Network (HVTN) von Broder, Gail B., Andrasik, Michele P., Karuna, Shelly T.

Volltext

Risk of COVID-19 after natural infection or vaccinationResearch in context von Anne-Marie Rick, Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas C.S. Martin, Carina A. Rodriguez, Christina A. Rostad, Rebone M. Maboa, Lindsey R. Baden, Hana M. El Sahly, Beatriz Grinsztejn, Glenda E. Gray, Cynthia L. Gay, Peter B. Gilbert, Holly E. Janes, James G. Kublin, Yunda Huang, Brett Leav, Ian Hirsch, Frank Struyf, Lisa M. Dunkle, Kathleen M. Neuzil, Lawrence Corey, Paul A. Goepfert, Stephen R. Walsh, Dean Follmann, Karen L. Kotloff, Atoya Adams, Eric Miller, Bruce G. Rankin, Steven Shinn, Marshall Nash, Sinikka L. Green, Colleen Jacobsen, Jayasree Krishnankutty, Sikhongi Phungwayo, Richard M. Glover, II, Stacy Slechta, Troy Holdeman, Robyn Hartvickson, Amber Grant, Terry L. Poling, Terry D. Klein, Thomas C. Klein, Tracy R. Klein, William B. Smith, Richard L. Gibson, Jennifer Winbigler, Elizabeth Parker, Priyantha N. Wijewardane, Eric Bravo, Jeffrey Thessing, Michelle Maxwell, Amanda Horn, Catherine Mary Healy, Christine Akamine, Laurence Chu, R. Michelle Chouteau, Michael J. Cotugno, George H. Bauer, Jr, Greg Hachigian, Masaru Oshita, Michael Cancilla, Kristen Kiersey, William Seger, Mohammed Antwi, Allison Green, Anthony Kim, Michael Desjardins, Jennifer A. Johnson, Amy Sherman, Stephen R. Walsh, Judith Borger, Nafisa Saleem, Joel Solis, Martha Carmen Medina, Westly Keating, Edgar Garcia, Cynthia Bueno, Nathan Segall, Douglas S. Denham, Thomas Weiss, Ayoade Avworo, Parke Hedges, Cynthia Becher Strout, Rica Santiago, Yvonne Davis, Patty Howenstine, Alison Bondell, Kristin Marks, Tina Wang, Timothy Wilkin, Mary Vogler, Carrie Johnston, Michele P. Andrasik, Jessica G. Andriesen, Gail Broder, Niles Eaton, Huub G. Gelderblom, Rachael McClennen

Volltext

Intentions to Use Preexposure Prophylaxis Among Current Phase 2B Preventive HIV-1 Vaccine Efficacy Trial Participants von Fuchs, Jonathan D, Sobieszczyk, Magdalena E, Madenwald, Tamra, Grove, Doug, Karuna, Shelly T, Andrasik, Michele, Sherwat, Adam, Broder, Gail, Mayer, Kenneth, Koblin, Beryl, Hammer, Scott

Volltext

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study von Dayan, Gustavo H., Rouphael, Nadine, Chen, Aiying, Grunenberg, Nicole, Bhate, Amit Suresh, Bonaparte, Matthew I., Celle, Médéric, Ceregido, Maria Angeles, Corey, Lawrence, Grillet, Marie-Helene, Keshtkar-Jahromi, Maryam, Kee, Jia Jin, Kaali, Seyram, Koutsoukos, Marguerite, Michael, Nelson L., Neuzil, Kathleen M., Reynales, Humberto, Robb, Merlin L., Uchiyama, Akiyoshi, Sawe, Fredrick, Schuerman, Lode, Treanor, John, Diazgranados, Carlos A., Gurunathan, Sanjay, Savarino, Stephen, Sridhar, Saranya, Abalos, Karina, Allaw, Mohamed, Aloysia, Naveena, Benkeser, David, Berge, Aude, Breuer, Thomas, Briesemeister, Liz, Broder, Gail, Calinescu, Cornell, Canter, Richard, Carrillo, Jaime Augusto, Chansinghakul, Danaya, Coux, Florence, Das, Chandan, Davies, Matthew, Devlin, Louis, Follmann, Dean, Frago, Carina, Fukase, Hiroyuki, Garinga, Agnes, Gilbert, Peter B., Gonzalez, Claudia, Granados, Maria Angelica, Greiwe, Cathy, Hall, Jessicalee, Henderson, Jeffrey, Hudzina, Kathy, Hural, John, Hutchens, Mark, Jennings, William, Kanodia, Piush, Kimmel, Murray, Kirby, William, Khandelwal, Nitin, Kosolsak, Chalit, Kublin, Jim, Kukian, Darshna, Laot, Thelma, Arroyo, Hugo Macareno, Mamod, Stephanie, Menard, Lisa, Mendoza, Sandra, Meyer, Robert, Middleton, Randle, Miracle, Jill, Mizuyama, Kazuyuki, Mohapatra, Satyajit, Moreau, Catherine, Murray, Linda, Newberg, Joseph, Noriega, Fernando, Nugent, Paul, Peake-Andrasik, Michele, Pekala, David, Peng, Penny, Py, Marie-Laure, Ramirez, Shelly, Reynolds, Michelle, Rivas, Enrique, Sater, Nessryne, Shah, Jinen, Sher, Lawrence, Sieger, Silva, Singh, Chandramani, Singh, Veer Bahadur, Sirisuphmitr, Nuchra, Starkey, Thomas, Suzuki, Kazuo, Tamrakar, Dipesh, Tangemen, Cayce, Taylor, David, Wartel, T. Anh, Zaworski, Elodie, Zhang, Nianxian

Volltext

Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial von Dawson, Liza, Garner, Sam, Anude, Chuka, Ndebele, Paul, Karuna, Shelly, Holt, Renee, Broder, Gail, Handibode, Jessica, Hammer, Scott M, Sobieszczyk, Magdalena E

Volltext

Implementing Good Participatory Practice (GPP) in HVTN505 - The HIV Vaccine Trials Network (HVTN) Experience von Broder, Gail B., Maynard, James P., Karuna, Shelly T., Anude, Chuka, Sobieszczyk, Magda E., Hammer, Scott M.

Volltext

Transgender Participants in the HIV Vaccine Trial Network's HVTN 505 Trial: A Descriptive and Comparative Analysis von Karuna, Shelly T., Grove, Doug, Broder, Gail B., Anude, Chuka, Hammer, Scott M., Sobieszczyk, Magda E., Andrasik, Michele P.

Volltext

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090) von Fuchs, Jonathan D., Frank, Ian, Elizaga, Marnie L., Allen, Mary, Frahm, Nicole, Kochar, Nidhi, Li, Sue, Edupuganti, Srilatha, Kalams, Spyros A., Tomaras, Georgia D., Sheets, Rebecca, Pensiero, Michael, Tremblay, Marc A., Higgins, Terry J., Latham, Theresa, Egan, Michael A., Clarke, David K., Eldridge, John H.

Volltext

Intentions to use pre-exposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants von Fuchs, Jonathan D., Sobieszczyk, Magdalena E., Madenwald, Tamra, Grove, Doug, Karuna, Shelly T., Andrasik, Michele, Sherwat, Adam, Broder, Gail, Mayer, Kenneth, Koblin, Beryl, Hammer, Scott

Volltext